General Characteristics of Metabolic Disruptions
Pathologies of nucleic acid metabolism are based on primary disorders in the synthesis and subsequent degradation reactions of purine and pyrimidine bases. These compounds play a fundamental role in maintaining normal body function by supporting DNA, RNA, as well as key nucleotide triphosphates and pyrophosphates. Any disruptions in these pathways inevitably impact cellular metabolism.
Pyrimidine Base Metabolism Disorders
Major pyrimidine structures include uracil, thymine, cytosine, as well as methyl- and hydroxymethylcytosine.
Main pathological conditions in this group:
- Hemolytic anemia — a systemic hematological disorder.
- Aminoisobutyric aciduria — a condition developing due to a deficiency of the enzyme 3-hydroxyisobutyrate dehydrogenase.
- Orotic acidemia and orotic aciduria — pathologies with an autosomal recessive inheritance pattern. The pathogenesis involves a block in the conversion of orotic acid to cytidylic acid. This causes excessive accumulation of the acid in tissues and its excretion in urine, and also provokes severe megaloblastic anemia.
Purine Base Metabolism Disorders
The purine group is represented by substances such as adenine, guanine, methyladenine, and methylguanine. In addition to participating in the structure of nucleic acids, they are components of essential high-energy compounds, including ATP, ADP, GTP, and GDP.
The final product of purine degradation is uric acid. Disorders in this metabolic branch manifest as:
- Hyperuricemia (elevated uric acid concentration);
- Hypouricemia (its decrease);
- Uricosuria / uraturia (excretion of urates in urine);
- Development of gout.